-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$209,400 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$143,718
Revance Therapeutics, Inc. Insider Transactions
Revance Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Jordan Erica
Chief Commercial Officer |
Sell | 2,392 @ $3.80 | $9,096 | 114,864 | 04/16/2024 | 04/17/2024 | |
|
Sjuts Dustin S
President |
Sell | 9,211 @ $5.04 | $46,446 | 167,550 | 03/18/2024 | 03/19/2024 | |
|
Moxie Dwight
CLO & GC |
Sell | 8,125 @ $5.04 | $40,971 | 137,815 | 03/18/2024 | 03/19/2024 | |
|
Schilke Tobin
CFO |
Sell | 9,361 @ $5.04 | $47,204 | 192,666 | 03/18/2024 | 03/19/2024 | |
|
Foley Mark J
CEO |
Buy | 30,000 @ $6.98 | $209,400 | 1,015,468 | 03/06/2024 | 03/08/2024 | |
|
Moxie Dwight
SVP, GC & Secretary |
Sell | 11,000 @ $17.06 | $187,704 | 44,066 | 09/06/2023 | 09/07/2023 | |
|
Moxie Dwight
SVP, GC & Secretary |
Sell | 23,853 @ $17.81 | $424,920 | 55,066 | 09/05/2023 | 09/07/2023 | |
|
Foley Mark J
CEO |
Sell | 26,279 @ $22.57 | $593,151 | 840,375 | 08/03/2023 | 08/04/2023 | |
|
Schilke Tobin
CFO |
Sell | 1,701 @ $25.04 | $42,593 | 79,896 | 07/03/2023 | 07/05/2023 | |
|
Foley Mark J
CEO |
Sell | 26,279 @ $24.94 | $655,333 | 866,654 | 07/03/2023 | 07/05/2023 | |
|
Kolaja Carey OConnor
Director |
Sell | 2,500 @ $28.24 | $70,600 | 16,561 | 06/15/2023 | 06/20/2023 | |
|
Sjuts Dustin S
President |
Sell | 5,000 @ $30.82 | $154,096 | 147,347 | 06/09/2023 | 06/13/2023 | |
|
Foley Mark J
CEO |
Sell | 31,279 @ $30.72 | $960,928 | 891,933 | 06/09/2023 | 06/13/2023 | |
|
Schilke Tobin
CFO |
Sell | 500 @ $31.00 | $15,500 | 80,828 | 06/02/2023 | 06/05/2023 | |
|
Schilke Tobin
CFO |
Sell | 2,701 @ $30.57 | $82,570 | 81,328 | 06/01/2023 | 06/05/2023 | |
|
Moxie Dwight
SVP, GC & Secretary |
Sell | 21,401 @ $34.55 | $739,338 | 69,165 | 05/15/2023 | 05/16/2023 | |
|
Schilke Tobin
CFO |
Sell | 21,401 @ $34.55 | $739,338 | 84,029 | 05/15/2023 | 05/16/2023 | |
|
Foley Mark J
CEO |
Sell | 70,447 @ $34.55 | $2.43 M | 923,212 | 05/15/2023 | 05/16/2023 | |
|
Sjuts Dustin S
President |
Sell | 21,015 @ $34.55 | $726,003 | 152,347 | 05/15/2023 | 05/16/2023 | |
|
Schilke Tobin
CFO |
Sell | 3,201 @ $31.70 | $101,472 | 63,081 | 05/01/2023 | 05/02/2023 |
Revance Therapeutics, Inc. Frequently Asked Questions
-
Who is on Revance Therapeutics, Inc.'s Insider Roster?
The list of insiders at Revance Therapeutics, Inc. includes Foley Mark J, Schilke Tobin, Moxie Dwight, Sjuts Dustin S, Jordan Erica.
-
How much insider selling is happening at Revance Therapeutics, Inc.?
Insiders have sold a total of 29,089 Revance Therapeutics, Inc. shares in the last 12 months for a total of 143,718 sold.
-
Which Revance Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Revance Therapeutics, Inc. shares in the last 12 months: Schilke Tobin ($47,204), Moxie Dwight ($40,971), Sjuts Dustin S ($46,446), Jordan Erica ($9,096),
-
How much insider buying is happening at Revance Therapeutics, Inc.?
Insiders have purchased a total of 30,000 Revance Therapeutics, Inc. shares in the last 12 months for a total of 209,400 sold.
-
Which Revance Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Revance Therapeutics, Inc. shares in the last 12 months: Foley Mark J ($209,400),